NMR Experiment |
---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
---|
1 | 2D 1H-1H NOESY | 1mM DNA (5'-D(*AP*AP*CP*AP*AP*TP*TP*GP*TP*T)-3'); 1mM Pyrrolo[2,1-c][1,4]benzodiazepine-Naphthalimide Hybrid; 100mM sodium chloride; 20mM sodium phosphate; 90% H2O/10% D2O | 90% H2O/10% D2O | 0.28 | 7 | ambient | 298 | |
2 | 2D 1H-1H NOESY | 1mM DNA (5'-D(*AP*AP*CP*AP*AP*TP*TP*GP*TP*T)-3'); 1mM Pyrrolo[2,1-c][1,4]benzodiazepine-Naphthalimide Hybrid; 100mM sodium chloride; 20mM sodium phosphate; 100% D2O | 100% D2O | |
3 | 2D DQF-COSY | 1mM DNA (5'-D(*AP*AP*CP*AP*AP*TP*TP*GP*TP*T)-3'); 1mM Pyrrolo[2,1-c][1,4]benzodiazepine-Naphthalimide Hybrid; 100mM sodium chloride; 20mM sodium phosphate; 100% D2O | 100% D2O | |
4 | 2D 1H-1H TOCSY | 1mM DNA (5'-D(*AP*AP*CP*AP*AP*TP*TP*GP*TP*T)-3'); 1mM Pyrrolo[2,1-c][1,4]benzodiazepine-Naphthalimide Hybrid; 100mM sodium chloride; 20mM sodium phosphate; 100% D2O | 100% D2O | |
5 | 2D-1H-1H ROESY | 1mM DNA (5'-D(*AP*AP*CP*AP*AP*TP*TP*GP*TP*T)-3'); 1mM Pyrrolo[2,1-c][1,4]benzodiazepine-Naphthalimide Hybrid; 100mM sodium chloride; 20mM sodium phosphate; 100% D2O | 100% D2O | |
6 | 2D 31P-1H HETCOR | 1mM DNA (5'-D(*AP*AP*CP*AP*AP*TP*TP*GP*TP*T)-3'); 1mM Pyrrolo[2,1-c][1,4]benzodiazepine-Naphthalimide Hybrid; 100mM sodium chloride; 20mM sodium phosphate; 100% D2O | 100% D2O | |